SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-19-031957
Filing Date
2019-06-21
Accepted
2019-06-21 19:01:37
Documents
2
Period of Report
2019-06-20

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tv524023_4.html 4  
1 OWNERSHIP DOCUMENT tv524023_4.xml 4 6118
2 EXHIBIT 24.1 tv524023_ex24-1.htm EX-24.1 10466
  Complete submission text file 0001144204-19-031957.txt   18046
Mailing Address 10 HUDSON YARDS, 37TH FLOOR New York NY 10001
Business Address 10 HUDSON YARDS, 37TH FLOOR NEW YORK NY 10001 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Issuer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 900 FIFTH AVENUE #8C NEW YORK NY 10021
Business Address
Gottesdiener Keith Michael (Reporting) CIK: 0001615856 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35668 | Film No.: 19912803